Resumen de Confidence booster.
This article discusses the challenges faced by pharmaceutical companies seeking to develop and market cancer vaccines. A metanalysis of data from the testing of a prostate cancer vaccine by Dendreon Corp. is presented and its incremental improvement of the prognosis for cancer patients is lauded. The recommendation that prevention of death, rather than the shrinking of the tumor, should serve as the endpoint to vaccine trials is explored.
